ERBB2 and breast carcinoma: We evaluated ADTD separately for triple-negative breast cancer (TNBC), human epidermal growth factor receptor 2-positive breast cancer (HER2+), luminal A (LumA), and luminal B (LumB) breast cancer to study common and complementary cell-type specific gene regulation.